Product
IMB-1018972
4 clinical trials
7 indications
Indication
Hypertrophic CardiomyopathyIndication
Type 2 DiabetesIndication
Diabetic CardiomyopathyIndication
Chronic Chest PainIndication
IschemiaIndication
Coronary Artery DiseaseClinical trial
A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic CardiomyopathyStatus: Completed, Estimated PCD: 2023-09-18
Clinical trial
A Pharmacodynamic Study to Evaluate the Effects of IMB-1018972 on Myocardial Energetics, Metabolism, and Function in Patients With Type 2 Diabetes.Status: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
A Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Refractory AnginaStatus: , Estimated PCD: 2025-02-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery DiseaseStatus: Completed, Estimated PCD: 2023-09-21